Evaluation of Bone Turnover Markers in Patients with Acute and Chronic Leukemia
Reem A Al-Qaisi1, Abdulnasser M Al-Gebori1, Mohammed Hadi Munshed Alosami2
1Department of Applied Sciences, Applied Chemists Division, University of Technology, Baghdad, Iraq.
Abstract:
This study investigated different bone biomarkers (cross-linked carboxy-terminal telopeptide of type 1 collagen (CTX-1), pyridinoline (PYD), osteocalcin (OC), interleukin-6 receptor (IL-6R), calcium (Ca), and magnesium (Mg)) in terms of their metabolism in 4 different leukemia subtypes (ALL, AML, CLL and CML). The design was case control study with 30 controls and 60 cases of leukemia patients. Authors have reported many results regarding decrease as well as increase of specific bone biomarker under investigation with each leukemia subtype when compared to control. In addition, Authors reported correlations between each biomarker level and leukemia subtypes.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...


